- Home
- DOYU vs MXCT Comparison
DOYU vs MXCT Comparison
Compare DOYU & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOYU
- MXCT
- Stock Information
- Founded
- DOYU 2014
- MXCT 1999
- Country
- DOYU China
- MXCT United States
- Employees
- DOYU N/A
- MXCT N/A
- Industry
- DOYU Computer Software: Programming Data Processing
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DOYU Technology
- MXCT Health Care
- Exchange
- DOYU Nasdaq
- MXCT Nasdaq
- Market Cap
- DOYU 485.3M
- MXCT 534.8M
- IPO Year
- DOYU 2019
- MXCT 2021
- Fundamental
- Price
- DOYU $7.20
- MXCT $3.85
- Analyst Decision
- DOYU Strong Sell
- MXCT Strong Buy
- Analyst Count
- DOYU 3
- MXCT 2
- Target Price
- DOYU $7.03
- MXCT $9.50
- AVG Volume (30 Days)
- DOYU 281.8K
- MXCT 436.4K
- Earning Date
- DOYU 03-25-2025
- MXCT 03-11-2025
- Dividend Yield
- DOYU 545.83%
- MXCT N/A
- EPS Growth
- DOYU N/A
- MXCT N/A
- EPS
- DOYU N/A
- MXCT N/A
- Revenue
- DOYU $631,661,209.00
- MXCT $45,599,000.00
- Revenue This Year
- DOYU N/A
- MXCT N/A
- Revenue Next Year
- DOYU N/A
- MXCT $20.23
- P/E Ratio
- DOYU N/A
- MXCT N/A
- Revenue Growth
- DOYU N/A
- MXCT 19.85
- 52 Week Low
- DOYU $6.29
- MXCT $3.17
- 52 Week High
- DOYU $20.17
- MXCT $5.26
- Technical
- Relative Strength Index (RSI)
- DOYU 19.08
- MXCT 35.05
- Support Level
- DOYU $15.25
- MXCT $4.06
- Resistance Level
- DOYU $16.99
- MXCT $4.32
- Average True Range (ATR)
- DOYU 0.59
- MXCT 0.20
- MACD
- DOYU -0.70
- MXCT -0.07
- Stochastic Oscillator
- DOYU 6.23
- MXCT 4.65
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.